Cached score snapshot
US.BAX · Baxter International
110分制 54.9/110;5D動能v2 31/50;排序分 85.9/160
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | Win rate | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | -0.24% | -2.03% / +1.64% | 46.2% | 6.2% | Actual outcome pending · 0 / 3 bars observed |
| 30D observation | +2.97% | -3.85% / +9.06% | 61.4% | 22.6% | Actual outcome pending · 0 / 30 bars observed |
| Historical projection 10D n=160 | -0.36% | -2.31% / +1.53% | 41.9% | 3.8% | Actual outcome pending · 0 / 10 bars observed |
Historical projection is based on archived similar setups. It is not a recommendation or guaranteed forecast.
2026-05-01 → 2026-09-08 · 150 archived points · 3 Improving turn signal · 6 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 22.5 · 資金流 13.2 · 5D動能v2 31
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 2.1/5 · 較差
Sub-items
資金流 — 13.2/20 · 一般
Sub-items
institutional
details
warning
市場環境 — 5.4/15 · 較差
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 6.7/10 · 一般
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 22.5/30 · 良好
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 3/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 2.1/5分 資金流分析總分: 13.2/20分 市場環境分析總分: 5.4/15分 催化劑分析: 2/20分 風險管理總分: 6.7/10分 技術信號分析總分: 22.5/30分 情緒分析: 3/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.1,
"details": {
"atrPct": 3.4731226918342224,
"turnoverUsdM": 143.39983049,
"liquidityPoints": 0.4,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.8,
"stopLevels": {
"symbol": "US.BAX",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 22.6772,
"strength_details": {
"ma_score": 1.5,
"atr_score": 1,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.6,
"stop_loss_percent": 6.9,
"take_profit_price": 27.1011,
"target_multiplier": 2.2,
"technical_strength": 2.2,
"take_profit_percent": 11.2
},
"positionPoints": 1.1,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.6123818525519849,
"stopLossPercent": 6.946245383668445,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 85.9,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 54.9,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 31
},
"market": {
"ma20": 22.422,
"ma50": 20.7564,
"close": 24.37,
"prevClose": 23.34,
"avgVolume20": 5556704,
"volumeRatio": 1.06,
"changePercent": 4.41
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 31,
"details": {
"ret_5d": 0.09725348941918055,
"max_score": 50,
"max_total": 50,
"raw_total": 31,
"vcp_bonus": 0,
"vol_ratio": 1.0604985586441251,
"ret_points": 12,
"vol_points": 2,
"range_ratio": 1.554742718868595,
"volat_points": 4,
"day_range_pct": 0.04821501846532625,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 8,
"partial_history": false,
"pullback_points": 3,
"breakout_vol_bonus": 0,
"first_breakout_20d": true,
"return_window_days": 5,
"first_breakout_bonus": 2,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 85.9,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.1,
"label": "基本面",
"weight": "5/110",
"normalized": 42,
"contribution": 2.1
},
{
"raw": 13.2,
"label": "資金流",
"weight": "20/110",
"normalized": 66,
"contribution": 13.2
},
{
"raw": 5.4,
"label": "市場環境",
"weight": "15/110",
"normalized": 36,
"contribution": 5.4
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 6.7,
"label": "風險管理",
"weight": "10/110",
"normalized": 67,
"contribution": 6.7
},
{
"raw": 22.5,
"label": "技術信號",
"weight": "30/110",
"normalized": 75,
"contribution": 22.5
},
{
"raw": 3,
"label": "情緒分析",
"weight": "10/110",
"normalized": 30,
"contribution": 3
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "避免",
"result": 54.9,
"details": [
"基本面分析總分: 2.1/5分",
"資金流分析總分: 13.2/20分",
"市場環境分析總分: 5.4/15分",
"催化劑分析: 2/20分",
"風險管理總分: 6.7/10分",
"技術信號分析總分: 22.5/30分",
"情緒分析: 3/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.1,
"資金流": 13.2,
"市場環境": 5.4,
"情緒分析": 3,
"技術信號": 22.5,
"風險管理": 6.7
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 6,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.5,
"pePoints": 0,
"epsPoints": 0,
"roePoints": 0,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 143.39983049,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0.3,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "一般",
"items": {
"cmfPoints": 1.6,
"mfiPoints": 3.2,
"obvPoints": 3.2,
"vwapPoints": 3.2,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.BAX",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 1.8,
"details": {
"source": "twelvedata+fred",
"vixClose": 18.67
}
},
"trend": {
"score": 0.8,
"details": {
"qqq": {
"ma20": 708.0634979000001,
"ma50": 716.7494019999999,
"name": "QQQ",
"close": 675.48999,
"points": 0.4
},
"spy": {
"ma20": 746.6510067000002,
"ma50": 744.8574021799999,
"name": "SPY",
"close": 740.85999,
"points": 0.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 3.4731226918342224,
"atrPoints": 2,
"cciPoints": 0.8,
"vixPoints": 1.8,
"marketTrendPoints": 0.8
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 3,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 6,
"negativeHits": 0,
"positiveHits": 1,
"sentimentScoreRaw": 0.4
}
},
"sentimentData": {
"raw": [
{
"id": 141040357,
"url": "https://finnhub.io/api/news?id=5b68a5449756cb77be3fa60595d044e46a65ddbdfc31c42aaf32c9ebd37c7990",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of",
"category": "company",
"datetime": 1785211982,
"headline": "Why Baxter (BAX) Stock Is Up Today"
},
{
"id": 140995061,
"url": "https://finnhub.io/api/news?id=db23a00dbadf1632408d3346471e8697b520ed9dfae62199e89d17d199b750c0",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"category": "company",
"datetime": 1784815204,
"headline": "Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline"
},
{
"id": 140922903,
"url": "https://finnhub.io/api/news?id=b5275a01614690b3553f7d84214cfd6f5edddbea6d87e4155056cc235f474a0d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months while the S&P 500 has gained 8.7%.",
"category": "company",
"datetime": 1784222962,
"headline": "3 Reasons to Avoid BAX and 1 Stock to Buy Instead"
},
{
"id": 140831700,
"url": "https://finnhub.io/api/news?id=bdca05e54b73cce68bcbc92c7d914a17c17db63875e119cfbd3541b5bc33a5fa",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Index additions put fresh attention on Baxter International Baxter International (BAX) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a shift that can influence index tracking flows and bring the stock onto more investor radars. See our latest analysis for Baxter International. Recent price action reflects that attention. Baxter International’s share price is US$22.58, with a 30-day share price return of 16.51% and a 90-day share price return of 35.86%...",
"category": "company",
"datetime": 1783437460,
"headline": "Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?"
},
{
"id": 140831701,
"url": "https://finnhub.io/api/news?id=540300aef1039a0c5f3bd5176a5e695e538aba143d506b23c7473b2ff6b6d9db",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter International Inc. was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, expanding its presence among US equity indices and index-tracking portfolios. This dual index inclusion, combined with broadly positive sentiment and supportive near- and mid-term outlooks, has drawn fresh attention from institutional investors and quantitative trading strategies focused on the stock. We’ll now examine how Baxter’s new Russell 2500 inclusion, alongside...",
"category": "company",
"datetime": 1783433501,
"headline": "Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?"
},
{
"id": 140832327,
"url": "https://finnhub.io/api/news?id=1f2f9710c3a6500f798e20b31ccf18aa99dd02281a5083045d6a3118b8c9bdf9",
"image": "https://image.cnbcfm.com/api/v1/image/108331141-17833752641783375262-47000887666-1080pnbcnews.jpg?v=1783375263&w=1920&h=1080",
"source": "CNBC",
"related": "BAX",
"summary": "CNBC’s “Fast Money” team shares their final trades of the day.",
"category": "company",
"datetime": 1783361006,
"headline": "Final Trade: BAX, TSLA, DRAM, GDX"
}
],
"raw_source": [
{
"id": 141050066,
"url": "https://finnhub.io/api/news?id=5821b8f0699b65c18a1faaa7007cc8787772feced6cf9d55e9eb04dd75ed0ffd",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "UBS analyst Patrick Wood maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $25.",
"category": "company",
"datetime": 1785251655,
"headline": "UBS Maintains Neutral on Baxter International, Raises Price Target to $25"
},
{
"id": 141050067,
"url": "https://finnhub.io/api/news?id=22bc36b9d33d7b2e004987b217f7709abeeefa0b8d64f9064e5fec5baa41815d",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $19 to $24.",
"category": "company",
"datetime": 1785235324,
"headline": "Stifel Maintains Hold on Baxter International, Raises Price Target to $24"
},
{
"id": 141040357,
"url": "https://finnhub.io/api/news?id=5b68a5449756cb77be3fa60595d044e46a65ddbdfc31c42aaf32c9ebd37c7990",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of",
"category": "company",
"datetime": 1785211982,
"headline": "Why Baxter (BAX) Stock Is Up Today"
},
{
"id": 141038252,
"url": "https://finnhub.io/api/news?id=f4a4559b5b850caa4d2b8b4706d2fff61de0ed7a357e903f58d4b8e4681acf97",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.",
"category": "company",
"datetime": 1785192302,
"headline": "3 Unprofitable Stocks That Fall Short"
},
{
"id": 141034536,
"url": "https://finnhub.io/api/news?id=92dcb8ac7576fe5ff634c1d302510a6bc71b737f528929fdca6bf34d39670d18",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $20 to $24.",
"category": "company",
"datetime": 1785149154,
"headline": "TD Cowen Maintains Hold on Baxter International, Raises Price Target to $24"
},
{
"id": 141008023,
"url": "https://finnhub.io/api/news?id=f8f30bf84e1e15f6f6e57395b4c780f642075ee558f77c259033ceff89883108",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.",
"category": "company",
"datetime": 1784906460,
"headline": "Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?"
},
{
"id": 140995061,
"url": "https://finnhub.io/api/news?id=db23a00dbadf1632408d3346471e8697b520ed9dfae62199e89d17d199b750c0",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"category": "company",
"datetime": 1784815204,
"headline": "Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline"
},
{
"id": 140981107,
"url": "https://finnhub.io/api/news?id=6ac2b5933542dcd98e2e2e1302ec766992726916b32e83acad878ea4b34b42ae",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
"category": "company",
"datetime": 1784716707,
"headline": "1 S&P 500 Stock for Long-Term Investors and 2 We Find Risky"
},
{
"id": 140948764,
"url": "https://finnhub.io/api/news?id=242adb6d5a3818f92451aceba654f7dc3d15514ebe1a5e1a61b2d0cacef77720",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323873733/image_1323873733.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "BAX",
"summary": "Baxter (BAX) stock rebounds 21% YTD after Q1 beat, but debt and muted growth cap upside near $22 fair value.",
"category": "company",
"datetime": 1784413326,
"headline": "Baxter: The Chart Points Higher, Valuation And Growth Are Less Appealing"
},
{
"id": 140922903,
"url": "https://finnhub.io/api/news?id=b5275a01614690b3553f7d84214cfd6f5edddbea6d87e4155056cc235f474a0d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months while the S&P 500 has gained 8.7%.",
"category": "company",
"datetime": 1784222962,
"headline": "3 Reasons to Avoid BAX and 1 Stock to Buy Instead"
},
{
"id": 140920976,
"url": "https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.",
"category": "company",
"datetime": 1784210345,
"headline": "Why Abbott Stock Is Reimagining Its Future"
},
{
"id": 140049019,
"url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "",
"category": "company",
"datetime": 1784205329,
"headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
},
{
"id": 140907456,
"url": "https://finnhub.io/api/news?id=ea90e871f4bebe869edd06014cb31d2873975e46465444a66adc34fbae80de5c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "AbbVie and Baxter both flashed the same bullish technical signal this month, but one golden cross signals genuine momentum while the other masks a fundamentally broken business. Knowing which is which could protect your retirement income from a costly mistake.",
"category": "company",
"datetime": 1784115954,
"headline": "AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap"
},
{
"id": 140915088,
"url": "https://finnhub.io/api/news?id=ab284d63df7e87bf80758c01d9b8b65a5e3132d2aceaecdc57a9a6705ec6b0eb",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $21.",
"category": "company",
"datetime": 1784114662,
"headline": "Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21"
},
{
"id": 140907548,
"url": "https://finnhub.io/api/news?id=89532ae5ac01cfa76fe574eb412f71bd7fa0e7e53888b0375cda378132492a48",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
"category": "company",
"datetime": 1784113757,
"headline": "3 Cash-Producing Stocks with Warning Signs"
},
{
"id": 140897584,
"url": "https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717",
"image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
"source": "ChartMill",
"related": "BAX",
"summary": "Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.",
"category": "company",
"datetime": 1784039701,
"headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
},
{
"id": 140091407,
"url": "https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "",
"category": "company",
"datetime": 1784034450,
"headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"
},
{
"id": 140855921,
"url": "https://finnhub.io/api/news?id=c3f1d29647d50538eea9159bdbb5db19431b7ed59cddc8ed4d114a14f39489ac",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "DEERFIELD, Ill., July 09, 2026--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday, July 30, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/167756971 to pre-register for the call and receive the call information.",
"category": "company",
"datetime": 1783627800,
"headline": "Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors"
},
{
"id": 140851034,
"url": "https://finnhub.io/api/news?id=fbd429437af6da7e6d6db2fb997ec0ff61cd8b8ed5974cd91a1292b6aa3b7500",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Retia Medical, the developer of cardiovascular intelligence software that transforms routine physiologic monitoring data into actionable clinical insight, today announced the appointment of Christopher Benassi, former Vice President, Connected Care Group at Baxter International, to its Strategic Advisory Board.",
"category": "company",
"datetime": 1783601580,
"headline": "Retia Medical Appoints Christopher Benassi to Strategic Advisory Board"
},
{
"id": 140850105,
"url": "https://finnhub.io/api/news?id=ce0913844bbfe462e69b9fb5cc1739fbf15ce70eb94ca1ed4fb38cc13cb73b83",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 10% over the past six months, topping the S&P 500 by 2.3 percentage points.",
"category": "company",
"datetime": 1783597740,
"headline": "3 Healthcare Stocks We Think Twice About"
},
{
"id": 140843626,
"url": "https://finnhub.io/api/news?id=943d08e631e5a9f541203c25926fd77cae5bf3f6b369a5ad404685a382eaa2e4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter International will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip.",
"category": "company",
"datetime": 1783509287,
"headline": "Baxter International's Q2 2026 Earnings: What to Expect"
},
{
"id": 140831700,
"url": "https://finnhub.io/api/news?id=bdca05e54b73cce68bcbc92c7d914a17c17db63875e119cfbd3541b5bc33a5fa",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Index additions put fresh attention on Baxter International Baxter International (BAX) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a shift that can influence index tracking flows and bring the stock onto more investor radars. See our latest analysis for Baxter International. Recent price action reflects that attention. Baxter International’s share price is US$22.58, with a 30-day share price return of 16.51% and a 90-day share price return of 35.86%...",
"category": "company",
"datetime": 1783437460,
"headline": "Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?"
},
{
"id": 140831701,
"url": "https://finnhub.io/api/news?id=540300aef1039a0c5f3bd5176a5e695e538aba143d506b23c7473b2ff6b6d9db",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Baxter International Inc. was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, expanding its presence among US equity indices and index-tracking portfolios. This dual index inclusion, combined with broadly positive sentiment and supportive near- and mid-term outlooks, has drawn fresh attention from institutional investors and quantitative trading strategies focused on the stock. We’ll now examine how Baxter’s new Russell 2500 inclusion, alongside...",
"category": "company",
"datetime": 1783433501,
"headline": "Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?"
},
{
"id": 140829561,
"url": "https://finnhub.io/api/news?id=83610d15f24312f54f0fce106677a786905765f5e1d75b5c1c3e9744ed6f2559",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "BAX",
"summary": "Pre-market stock analysis of S&P500 stocks on 2026-07-07: top gainers and losers in today's session.",
"category": "company",
"datetime": 1783427701,
"headline": "These S&P500 stocks are moving in today's pre-market session"
},
{
"id": 140829303,
"url": "https://finnhub.io/api/news?id=109ba7dd5aadf6a7767ddcfc93f90bfa91be93081fd9491b160ccae52fe40c77",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
"category": "company",
"datetime": 1783419952,
"headline": "3 Value Stocks We Keep Off Our Radar"
},
{
"id": 140832327,
"url": "https://finnhub.io/api/news?id=1f2f9710c3a6500f798e20b31ccf18aa99dd02281a5083045d6a3118b8c9bdf9",
"image": "https://image.cnbcfm.com/api/v1/image/108331141-17833752641783375262-47000887666-1080pnbcnews.jpg?v=1783375263&w=1920&h=1080",
"source": "CNBC",
"related": "BAX",
"summary": "CNBC’s “Fast Money” team shares their final trades of the day.",
"category": "company",
"datetime": 1783361006,
"headline": "Final Trade: BAX, TSLA, DRAM, GDX"
},
{
"id": 140823137,
"url": "https://finnhub.io/api/news?id=551923397eb0a7116ba7714942d334cfe2da380823998a5a044d2bd8c05bddcf",
"image": "",
"source": "Benzinga",
"related": "BAX",
"summary": "Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperform and raises the price target from $22 to $24.",
"category": "company",
"datetime": 1783338012,
"headline": "Evercore ISI Group Maintains Outperform on Baxter International, Raises Price Target to $24"
},
{
"id": 140802850,
"url": "https://finnhub.io/api/news?id=c5905c968be2d149392bf23b184b1bb711768e2b822b0fb6621edca56d2e06a8",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.",
"category": "company",
"datetime": 1783100460,
"headline": "WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?"
},
{
"id": 140792023,
"url": "https://finnhub.io/api/news?id=1b2cfcadbb8d51bc8a515709b049fcc4c163eaecd6b9d58fce0cdcc7a1a170b7",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "BAX",
"summary": "Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
"category": "company",
"datetime": 1783010101,
"headline": "These S&P500 stocks are moving in today's session"
},
{
"id": 140773587,
"url": "https://finnhub.io/api/news?id=b14d8a4a4df572ec5dd36dfce74c378ba4cad7af2cf47b716a9de2ed4398ade2",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "CorMedix broadens beyond DefenCath with Melinta assets, Rezzayo potential and cost synergies as reimbursement changes test long-term earnings durability.",
"category": "company",
"datetime": 1782832200,
"headline": "CRMD's Growth Story Expands Beyond DefenCath Into New Trends"
},
{
"id": 140765129,
"url": "https://finnhub.io/api/news?id=3b510a05254eac4da2d0a1d40f52879e479eca6c746029ac93824db3dbb6fbc7",
"image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "BAX",
"summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
"category": "company",
"datetime": 1782740122,
"headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
},
{
"id": 140760997,
"url": "https://finnhub.io/api/news?id=37f97fddf6554d546f7bb0d63aeba15b5d903c4d4968ff489d3e16554f75df15",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "BAX",
"summary": "Nate Baxter Appointed President and Chief Executive Officer Pete Shumlin Elected Chairman of the Board MARYSVILLE, Ohio, June 29, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that the Board of Directors has named Nate Baxter as president and CEO, effective immediately. In addition, Baxter has joined the Board of Directors. The Board also elected independent Lead Director Pe",
"category": "company",
"datetime": 1782730500,
"headline": "ScottsMiracle-Gro Announces Strategic Leadership Succession"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 6,
"negative_hits": 0,
"positive_hits": 1,
"recomputed_at_score": true,
"sentiment_score_raw": 0.4,
"source_article_count": 32,
"discarded_article_count": 26
},
"sentimentPoints": 3
}
},
"技術信號": {
"max": 30,
"raw": 22.5,
"grade": "良好",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 1.5,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 1.5,
"vcp_reason": "跌縮量(近10日3日);站上MA50;收盤突破20日高位;Ready=N;Confirm=Y",
"vcp_metrics": {
"up_days": 5,
"vol_ref": 6086650,
"down_days": 4,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 5195640,
"avg_vol_20": 5548595,
"avg_vol_30": 6086650,
"range_pct_10": 0.10463684858432501,
"range_pct_20": 0.10463684858432501,
"range_pct_30": 0.17767747230201072,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": false,
"down_shrink_ok": true,
"up_expand_days": 1,
"breakout_20d_ok": true,
"vol_ratio_10_30": 0.8536124140537077,
"dist_to_20d_high": -0.02783635596794602,
"down_shrink_days": 3,
"breakout_level_20d": 23.71,
"vcp_breakout_confirm": true,
"contraction_ratio_10_30": 0.5889145496535796
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.8,
"rsiKdjPoints": 3.2,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 0.8,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0.6,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "一般",
"items": {
"position": {
"score": 1.1,
"details": {
"atrPct": 3.4731226918342224,
"turnoverUsdM": 143.39983049,
"liquidityPoints": 0.4,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.8,
"stopLevels": {
"symbol": "US.BAX",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 22.6772,
"strength_details": {
"ma_score": 1.5,
"atr_score": 1,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.6,
"stop_loss_percent": 6.9,
"take_profit_price": 27.1011,
"target_multiplier": 2.2,
"technical_strength": 2.2,
"take_profit_percent": 11.2
},
"positionPoints": 1.1,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.6123818525519849,
"stopLossPercent": 6.946245383668445,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 100,
"atr": {
"atr": 0.8464,
"rule": "ATR / current price; lower volatility scores higher",
"score": 4,
"atr_pct": 3.47
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": 250.34
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "平衡",
"score": 4,
"value": 0.023
},
"kdj": {
"d": 52.33,
"j": 91.15,
"k": 65.27,
"rule": "Cursor_18.24 K/D cross",
"score": 6,
"signal": "強金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "入貨中",
"score": 8,
"value": 66.56
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 8,
"trend": "資金入貨",
"value": 78902877,
"recentSlope": 666167.7,
"previousSlope": 597650
},
"rsi": 65.58,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 21.2048,
"position": "SAR喺價下",
"distancePct": 12.99,
"previousTrend": "上升"
},
"ma50": 20.7564,
"macd": {
"macd": 0.6450189798653412,
"trend": "強烈看漲",
"signal": 0.6118193730065365,
"histogram": 0.03319960685880463
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 8,
"value": 22.4373,
"position": "連續3日>VWAP",
"consecutiveAbove": 3
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.06,
"score": 6,
"avgVolume": 5556704,
"currentVolume": 5884277
},
"derived": {
"ma20": 22.422,
"ma50": 20.7564,
"prevClose": 23.34,
"avgVolume10": 5279338,
"avgVolume20": 5556704,
"changePercent": 4.41,
"avgVolumeForScore": 5556704
},
"ma_cross": {
"ma20": 22.422,
"ma50": 20.7564,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 22.3045,
"prevMa50": 20.6246,
"spreadPct": 8.02,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 21.0456,
"upper": 23.7984,
"position": "上半部"
},
"rsi_short": 84.02,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.06
}
}
}
Raw metrics JSON
{
"close": 24.37,
"volume": 5884277,
"changePercent": 4.41
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.